Objective: To evaluate the National Newborn Screening Program (NNSP) coverage in the city of Maringá, from 2001 to 2006. Methods: This is a cross-sectional research design, which verified the number of live newborns as well as the number of screened children. The study considered the children born in Maringá as well as those born in other cities but living in Maringá. Results: The NNSP did not reach the expected coverage of 100% in Maringá during the first five years of evaluation. There is a need to consider certain particularities when performing data analysis, such as the period and the place of material collection. Conclusion: Changes should be made so as to improve NNSP coverage. Furthermore, the period when the blood sample was drawn should be reconsidered and decentralized with a view to improve health care delivery. Métodos: Se trata de un estudio observacional transversal retrospectivo. Fueron verificados el número de nacidos vivos y el número de niños rastreados, considerando los nacidos vivos en Maringá y los nacidos vivos residentes en Maringá. Resultados: La cobertura del PNTN en Maringá en los cinco primeros años evaluados, no alcanzó el objetivo deseado por el programa, o sea, el 100% de los nacidos vivos. Algunas consideraciones son necesarias en el análisis de los datos, una de ellas es la época y el local en que el material es recolectado. Conclusión: Se sugieren cambios que puedan ayudar a mejorar la cobertura del Programa de Triaje Neonatal, revisar la época de la recolección de la sangre y descentralizarla para ampliar el horizonte de atención.
INTRODUCTION
Three decades ago, children with metabolic diseases were born without any life expectancy (1) . As of the 1960s, the World Health Organization has promoted the development of neonatal screening programmes in developing countries. The WHO created criteria for the insertion of diseases; including high specificity and sensitivity of the disease in the population. Hence, laws have been passed to support the detection of genetic diseases with irreversible sequelae by means of Neonatal Screening Programmes (2) . In Brazil, the Ministerial Regulation number 822/01 (3) regulates the early detection of genetic diseases included in the National Neonatal Screening Programme (NNSP) -Phenylketonuria, Congenital Hypothyroidism, Hemoglobinopathy, and Cystic Fibrosis. To legitimate this law has been a challenge for the Single Health System (Sistema Unico de Saude), since it makes good results possible in health care delivery and management. The damages, with chronic characteristics, resulting from a late diagnosis determine the need for efficiency and precision of secondary prevention actions.
Neonatal screening was become compulsory in the State of São Paulo by Federal Law number 3914, on November 14, 1983 . Since then, all children born in the State Public Hospitals and Maternities were screened only for Congenital Hypothyroidism and Phenylketonuria (PKU). On July 13, 1990 , the Federal Law number 8069 instituted this programme compulsory for all Brazilian children (3) . Diseases are identified through a blood exam collected by heel puncture in the newborn. To facilitate the dissemination of this exam among the population, it was referred to as the "Heel Prick Test" (in Portuguese: Teste do Pezinho -Little Foot test) (4) . The NNSP has as objectives to increase the coverage of live newborn (LN) screening, aiming at 100%; the active search for screened patients; diagnosis confirmation and proper attendance (2) . In this sense, the NNSP tracks, diagnoses, and forwards the patients to the reference services to which they are connected, for example, The Brazilian Association of Mucoviscidosis (Associação Brasileira de Mucoviscidose) providing more quality and efficiency to the treatment (5) . In view of the different levels of organization of health care units in the many Brazilian States, the variation in screened LN coverage rates and the different population characteristics, the government established stages for administering the NNSP in each state. Stage I regards the detection of PKU and congenital hypothyroidism; Stage II, PKU, congenital hypothyroidism + falciform diseases and other hemoglobinopathies; stage III, PKU, congenital hypothyroidism, falciform diseases and other hemoglobinopathies + cystic fibrosis (5) . The criteria for stage evolution are based on the coverage rate of each state; for instance: a 50% coverage implies there is screening for Hemoglobinopathies; coverage up to 70% allows screening for Cystic Fibrosis (6) . The State of Paraná is in Stage III of the NNSP, but the government has included Biotinidase Deficiency (BIOT) in the screening, at their own cost. The municipal districts perform the blood collection after the first fortyeight hours of the newborn's life and send it to the reference service, the Ecumenical Foundation of Protection to Exceptional Individuals (Fundação Ecumênica de Proteção ao Excepcional -FEPE), located in Curitiba (5) . In Maringá, the material is collected in maternities and in the laboratory of the Municipal Health Bureau.
There is no doubt about the utility of neonatal screening for population health. Nevertheless, it is always necessary to evaluate the programme, which can result in objective arrangements to correct the any flaws (7) . The FEPE was established in 1961, as a Ecumenical School of Special Education and since 1974, it operates as a Research Centre in the detection of Innate Metabolism Errors. This philanthropic entity has the responsibility to investigate the screening tests for the early neonatal diagnosis and the prevention of sequelae by diseases (5) . It is a reference service for neonatal screening in Paraná, and, thus, is responsible for receiving the collected materials, doing research on the diseases, and providing the services with the exam results. When positive, they are committed to searching for the patient and family to provide diagnosis tests. On this everlasting journey, it has prevented 500 children from developing mental deficiency.
OBJECTIVE
The study comprised 28,247 LN, born or living in the city, and 20.529 LN screened in health services in Maringá in the referred period.
The data collected were organized and analysed using Excel (Microsoft). Tables 1 and 2 Any neonatal screening programme should target 100% coverage of LNs; i.e., the blood samples must be collected from every newborn (8) . A factor that can explain the results of the partial coverage of the NNSP is that the tests are performed by private laboratories, in which the data are not added to the official registers in the state. According to the records of the Health Ministry, in 2000, from the 3.000.000 LN, between a third and a half did not performs the test through the Programme (6) .
RESULTS
It is observed that NNSP coverage in Maringá remained within the average of 92.5% in the first four years, with an expressive reduction in 2005, 88.5%, and an increase to 98.4% in 2006. The alteration pointed out in the last two years can be justified by the number of LN in the end of 2005, that is, they were born in the last week of December, but the material collection was recorded under the following year, thus increasing the rate in about 10%. The prevalence of 98.4% in 2006 reflects the improvement of the Programme and the quality in health care delivered by the collection units (maternities and Health Bureaus) and the reduction in the number of collections done by private laboratories. Even though the prevalence found is below the targets established by the Programme, i.e., to reach 100% coverage. A study performed in 1995, in the State of Sergipe, showed a neonatal screening coverage of 15% (9) . In Campina Grande, Paraiba, a coverage of 32.2% was found (10) . In a research performed in the State of Santa Catarina, neonatal screening coverage was evaluated from 
DISCUSSION
The Neonatal Screening Programme of Paraná was one of the first programmes related to the evolution of the stages for establishing the screened diseases. Therefore, making the NNSP effective is considered a strategy to reduce infant mortality and improve the quality of life of the patient and family. Moreover, it also contributes to obtaining information about Table 2 -Distribution of the live newborns, residents, according to the coverage by the NNSP -National Neonatal Sreening Programme 1994 to 1998, revealing a rate of 81%, which reached 91.4% in 1997 (8) . The latter are very close to the figures found in this study, and are substantially different from the previous ones. These differences among Brazilian regions can reflect the country's social economic and cultural panorama.
Another (11) . However, it is necessary to consider the possibility that these figures might not reveal the real screening situation in Maringá, since the fact that these tests were performed by the private system makes it unfeasible to consider the official data.
In Maringá, the material is collected in maternities after the first 48 hours of the infant's life. In a natural delivery, it is common for mother and newborn to be discharged before the 48 hours are completed. This behaviour makes material collection in the maternity unfeasible. After this period, the collection is a responsibility of the Municipal Health Bureau, located in the city centre, which is of difficult access to the population with lower income and living in the city's outskirts.
According to the Brazilian Society of Neonatal Screening (12) , the ideal period for blood collection is between the third and the seventh day of life, however, never before completing 48 hours of life.
In Paraná State, it is demanded that material collection for the neonatal screening be performed after the first 48 hours of life (ideal between 48 and 120 hours) and before completing one month (13) . Some Neonatal Screening Programmes, as the one in Minas Gerais, for example, collect the material on the seventh day after the delivery. It has been shown that this is appropriate for a successful diagnosis, avoiding losses like postdelivery discharges (14) . Therefore, material collection is performed at basic health units and not in the maternities, as in Maringá.
CONCLUSION
The prevalence of the Neonatal Screening Programme coverage in Maringá, from 2001 to 2006, reached rates above 90%. Despite reaching an expressive coverage, it did not reach the target established by the screening Programme, although these data did not consider the tests performed in private laboratories.
The fact that Maringá is the reference for health services in the region implies that people born in the city, despite not living there, can be discharged before completing 48 hours, and, therefore, may not be reached by the screening.
However, this situation should not be considered exclusively responsible for the failure in reaching the target. A situation that could have contributed for not reaching the objective is the period and place where the collection was accomplished.
The fact that other collection centres, such as Basic Health Units (BHU), are responsible for collecting the material for the Neonatal Screening tends to increase coverage rates. This occurs because it is more feasible for the family to take their child to a BHU, since care delivery is not centralised, and thus makes the access easier to the population. In addition, the presence of the BHU is decisive to follow the child's health, more specifically by the Family Health Programme.
In Maringá, only the maternities or the Health Bureau collects blood samples for the "heel prick test". In some ways, this behaviour exempts every health institution from the responsibility of not collecting the blood or collecting it late. If a child is discharged from the hospital before completing 48 hours of life, the child can miss the exam and the services cannot be accounted for that, since maternities could not collect the material and the Health Bureau does not perform an active search, only waits for newborns to attend the service for the collection. This wearisome situation should be reconsidered with a view to maximise neonatal screening coverage.
This study led to conclusions that can could improve neonatal screening programme coverage, which are: to review the period when blood collection is performed, thus contributing to the access of live newborns, and decentralise services with a view to expand the delivery of health care.
